An Open-Label, Rollover Platform Study for Continued Study Treatment and Ongoing Safety Monitoring

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-515457-21-00

Acronym

PLATFORMPACAN1001

Enrollment

Registered

2024-12-16

Start date

2024-12-30

Completion date

Unknown

Last updated

2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Hodgkin lymphoma and chronic lymphocytic leukemia

None listed

Sex/Gender

All

Age

65 Years to No maximum

Belgium, France, Greece, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026